,

Grant M Downes1, Amber S Griffith2, Kyle D Apley3

  • 1Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045 United States.

Molecular pharmaceutics
|November 12, 2025
PubMed
概括

研究人员设计了具有阴性尾巴的亲胰岛素变体,以改善1型糖尿病的抗原特异性免疫疗法 (ASIT). 这种修改减缓了抗原的释放,增强了免疫耐受性,并可能减少了广泛免疫抑制的需要.